Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.33 |
| ▸ | MIF | P14174 | 2/20 | 0.33 |
| ▸ | PDE5A | O76074 | 2/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL590654 | 0.75 | EGFR (0.35) | EGFRADORA2AADORA1MIFPDE5A | |
| SCHEMBL51669 | 0.75 | KDM4E (0.41) | EGFRADORA2AADORA1MIFPDE5A | |
| SCHEMBL534883 | 0.73 | — | — | |
| SCHEMBL588347 | 0.70 | EGFR (0.34) | EGFRADORA2AADORA1MIFPDE5A | |
| SCHEMBL589112 | 0.70 | EGFR (0.34) | EGFRADORA2AADORA1MIFPDE5A | |
| SCHEMBL588359 | 0.69 | MPO (0.34) | ALDH1A1TSHRNPSR1 | |
| SCHEMBL588416 | 0.64 | KDM4E (0.36) | ALDH1A1NPSR1 | |
| SCHEMBL720139 | 0.63 | GPR3 (0.54) | ALDH1A1CYP1A2CYP2D6TSHRCYP2C19 | |
| SCHEMBL1841274 | 0.63 | EGFR (0.51) | EGFRADORA2AADORA1MIFPDE5A | |
| Hydrochloric Acid SCHEMBL3319819 | 0.62 | EGFR (0.50) | EGFRADORA2AADORA1MIFPDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0711768-B1 | BENZIMIDAZOLE DERIVATIVE | MITSUI CHEMICALS INC (JP) | 2002-02-13 | — | — | EP | claimed |
| US-20240237514-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240237512-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240237516-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LT MATERIALS CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-12018022-B2 | Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode | LT MATERIALS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| WO-2024128540-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2024-06-20 | — | — | WO | disclosed |
| US-20240206205-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER | LT MATERIALS CO., LTD. (KR) | 2024-06-20 | — | — | US | disclosed |
| US-20240206324-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | LT MATERIALS CO., LTD. (KR) | 2024-06-20 | — | — | US | disclosed |
| EP-4378939-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER | LT Materials Co., Ltd. (KR) | 2024-06-05 | — | — | EP | disclosed |
| US-12004420-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2024-06-04 | — | — | US | disclosed |
| US-20140088066-A1 | PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | BLEND THERAPEUTICS (US) | 2014-03-27 | — | — | US | disclosed |
| US-20120097937-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-8114530-B2 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-14 | — | — | US | disclosed |
| US-7968213-B2 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-06-28 | — | — | US | disclosed |
| EP-2166583-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT PREPARED BY USING THE MATERIAL | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-24 | — | — | EP | disclosed |
| EP-2166584-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT PREPARED BY USING THE MATERIAL | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-24 | — | — | EP | disclosed |
| US-20090017331-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090017330-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-0851865-B1 | 12H-Dibenzo[d,g][1,3]dioxocine derivatives | NOVO NORDISK AS (DK) | 2002-07-17 | — | — | EP | disclosed |
| US-5972925-A | 1-(3-(2-CHLORO-12H-DIBENZO(D,G)(1,3,6)DIOXAZOCIN-12-YL)-1-PROP YL)-3-PIPERIDINECARBOXYLIC ACID, FOR EXAMPLE; TREATING NEUROGENIC PAIN (IN WHICH C-FIBERS PLAY A ROLE) OR INFLAMMATION SUCH AS MIGRAINE OR DIABETIC NEUROPATHY | NOVO NORDISK A/S (DK) | 1999-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018022-B2 | Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode | ODC1, AOX1, CYP1B1 | EGFR 3462/4885ADORA2A 3452/4885ADORA1 2017/4885 |
| US-20140088066-A1 | PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | APEX1, DPYD, VHL | EGFR 893/4885ADORA2A 3035/4885ADORA1 3747/4885 |
| US-20240206205-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER | CRY1, ORC3, CYP1A1 | EGFR 3514/4885ADORA2A 3093/4885ADORA1 1342/4885 |
| US-20240237516-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CCNL2, CRY1, CRY2 | EGFR 3076/4885ADORA2A 1889/4885ADORA1 542/4885 |
| US-20090017330-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | ICMT, ORAI2, ILK | EGFR 3401/4885ADORA2A 3760/4885ADORA1 3871/4885 |
| US-20240237512-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CRY1, SUN2, CRY2 | EGFR 4156/4885ADORA2A 2777/4885ADORA1 3915/4885 |
| US-20090017331-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | ICMT, ORAI2, ILK | EGFR 3401/4885ADORA2A 3760/4885ADORA1 3871/4885 |
| US-20240237514-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER | CYP1A1, CYP1B1, CYP2E1 | EGFR 3859/4885ADORA2A 2722/4885ADORA1 1402/4885 |
| US-20240206324-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | CYP1B1, CYP4F11, CYP1A1 | EGFR 3483/4885ADORA2A 4028/4885ADORA1 1672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.